Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Differential Distribution of miR-20a and miR-20b may Underly Metastatic Heterogeneity of Breast Cancers

  • Li, Jian-Yi (Department of Breast Surgery, Shengjing Hospital of China Medical University) ;
  • Zhang, Yang (Department of Breast Surgery, Shengjing Hospital of China Medical University) ;
  • Zhang, Wen-Hai (Department of Breast Surgery, Shengjing Hospital of China Medical University) ;
  • Jia, Shi (Department of Breast Surgery, Shengjing Hospital of China Medical University) ;
  • Kang, Ye (Department of Breast Surgery, Shengjing Hospital of China Medical University) ;
  • Zhu, Xiao-Yu (Department of Breast Surgery, Shengjing Hospital of China Medical University)
  • Published : 2012.05.30
Download PDF
⟨ Previous Next ⟩

Abstract

Background: The discovery that microRNA (miRNA) regulates metastasis provide a principal molecular basis for tumor heterogeneity. A characteristic of solid tumors is their heterogenous distribution of blood vessels, with significant hypoxia occurring in regions (centers of tumor) of low blood flow. It is necessary to discover the mechanism of breast cancer metastasis in relation to the fact that there is a differential distribution of crucial microRNA in tumors from centers to edges. Methods: Breast tissues from 48 patients (32 patients with breast cancer) were classified into the high invasive and metastatic group (HIMG), low invasive and metastatic group (LIMG), and normal group. Samples were collected from both the centers and edges of all tumors. The first six specimens were detected by microRNA array, and the second ten specimens were detected by real-time qRT-PCR and Western blot analyses. Correlation analysis was performed between the miRNAs and target proteins. Results: The relative content of miR-20a and miR-20b was lower in the center of the tumor than at the edge in the LIMG, lower at the edge of the tumor than in the center in the HIMG, and lower in breast cancer tissues than in normal tissues. VEGF-A and HIF-1alpha mRNA levels were higher in the HIMG than in the LIMG, and levels were higher in both groups than in the normal group; there was no difference in mRNA levels between the edge and center of the tumor. VEGF-A and HIF-1alpha protein levels were higher in the HIMG than in the LIMG, and protein levels in both groups were higher than in the normal group; there was a significant difference in protein expression between the edge and center of the tumor. Correlation analysis showed that the key miRNAs (miR-20a and miR-20b) negatively correlated with the target proteins (VEGF-A and HIF-1alpha). Conclusions: Our data suggest that miR-20a and miR-20b are differentially distributed in breast cancer, while VEGF-A and HIF-1alpha mRNA had coincident distributions, and VEGF-A and HIF-1alpha proteins had uneven and opposing distributions to the miRNAs. It appears that one of the most important facets underlying metastatic heterogeneity is the differential distribution of miR-20a and miR-20b and their regulation of target proteins.

Keywords

References

  1. Balsat C, Blacher S, Signolle N, et al (2011). Whole slide quantification of stromal lymphatic vessel distribution and peritumoral lymphatic vessel density in early invasive cervical cancer: a method description. ISRN Obstet Gynecol, 25, 1-7.
  2. Choi SB, Park JB, Song TJ, Choi SY (2011). Molecular mechanism of HIF-1-independent VEGF expression in a hepatocellular carcinoma cell line. Int J Mol Med, 28, 449-54.
  3. Desantis C, Siegel R, Bandi P, Jemal A (2011). Breast cancer statistics. CA Cancer J Clin, 61, 409-18.
  4. Fan X, Liu Y, Jiang J, et al (2010). miR-20a promotes proliferation and invasion by targeting APP in human ovarian cancer cells. Acta Biochim Biophys Sin (Shanghai), 42, 318-24. https://doi.org/10.1093/abbs/gmq026
  5. Gerhardt H, Golding M, Fruttiger M, et al (2003). VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol, 161, 1163-77. https://doi.org/10.1083/jcb.200302047
  6. Guidi AJ, Schnitt SJ, Fischer L, et al (1997). Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast. Cancer, 80, 1945-53. https://doi.org/10.1002/(SICI)1097-0142(19971115)80:10<1945::AID-CNCR11>3.0.CO;2-Y
  7. Hafez MM, Hassan ZK, Zekri AR, et al (2012). MicroRNAs and metastasis-related gene expression in egyptian breast cancer patients. Asian Pac J Cancer Prev, 13, 591-8. https://doi.org/10.7314/APJCP.2012.13.2.591
  8. Heimann R, Hellman S (1998). Aging, progression, and phenotype in breast cancer. J Clin Oncol, 16, 2686-92. https://doi.org/10.1200/JCO.1998.16.8.2686
  9. Kim J, Oh WJ, Gaiano N, Yoshida Y, Gu C (2011). Semaphorin 3E-Plexin-D1 signaling regulates VEGF function in developmental angiogenesis via a feedback mechanism. Genes Dev, 25, 1399-411. https://doi.org/10.1101/gad.2042011
  10. Letonqueze O, Lee J, Vasudevan S (2012). MicroRNA-mediated posttranscriptional mechanisms of gene expression in proliferating and quiescent cancer cells. RNA Biol, 9, 871-80. https://doi.org/10.4161/rna.20806
  11. Linderholm B, Lindh B, Tavelin B, Grankvist K, Henriksson R (2000). p53 and vascular-endothelial-growth-factor (VEGF) expression predicts outcome in 833 patients with primary breast carcinoma. Int J Cancer, 89, 51-62. https://doi.org/10.1002/(SICI)1097-0215(20000120)89:1<51::AID-IJC9>3.0.CO;2-8
  12. Nana-Sinkam SP, Croce CM (2011). Non-coding RNAs in cancer initiation and progression and as novel biomarkers. Mol Oncol, 5, 483-91. https://doi.org/10.1016/j.molonc.2011.10.003
  13. Osinsky S, Bubnovskaya L, Ganusevich I, et al (2011). Hypoxia, tumour-associated macrophages, microvessel density, VEGF and matrix metalloproteinases in human gastric cancer: interaction and impact on survival. Clin Transl Oncol, 13, 133-8. https://doi.org/10.1007/s12094-011-0630-0
  14. Pesta M, Klecka J, Kulda V, et al (2010). Importance of miR- 20a expression in prostate cancer tissue. Anticancer Res, 30, 3579-83.
  15. Piao HL, Ma L (2012). Non-coding RNAs as regulators of mammary development and breast cancer. J Mammary Gland Biol Neoplasia, 17, 33-42. https://doi.org/10.1007/s10911-012-9245-5
  16. Schindl M, Schoppmann SF, Samonigg H, (2002). Austrian Breast and Colorectal Cancer Study Group. Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer. Clin Cancer Res. 8, 1831-7.
  17. Secomb TW, Dewhirst MW, Pries AR (2012). Structural adaptation of normal and tumour vascular networks. Basic Clin Pharmacol Toxicol, 110, 63-9. https://doi.org/10.1111/j.1742-7843.2011.00815.x
  18. Voorhoeve PM (2010). MicroRNAs: Oncogenes, tumor suppressors or master regulators of cancer heterogeneity? Biochim Biophys Acta, 1805, 72-86.

Cited by

  1. Aberrant Expression of miR-20a and miR-203 in Cervical Cancer vol.14, pp.4, 2013, https://doi.org/10.7314/APJCP.2013.14.4.2289
  2. Differential Distribution of microRNAs in Breast Cancer Grouped by Clinicopathological Subtypes vol.14, pp.5, 2013, https://doi.org/10.7314/APJCP.2013.14.5.3197
  3. miR-20a is an independent prognostic factor in colorectal cancer and is involved in cell metastasis vol.10, pp.1, 2014, https://doi.org/10.3892/mmr.2014.2144
  4. Contrast enhanced computed tomography is indicative for angiogenesis pattern and display prognostic significance in breast cancer vol.14, pp.1, 2014, https://doi.org/10.1186/1471-2407-14-672
  5. MicroRNAs in hypoxia and acidic tumor microenvironment vol.59, pp.19, 2014, https://doi.org/10.1007/s11434-014-0273-y
  6. Effect of miR-20b on Apoptosis, Differentiation, the BMP Signaling Pathway and Mitochondrial Function in the P19 Cell Model of Cardiac Differentiation In Vitro vol.10, pp.4, 2015, https://doi.org/10.1371/journal.pone.0123519
  7. MicroRNA-20b-5p functions as a tumor suppressor in renal cell carcinoma by regulating cellular proliferation, migration and apoptosis vol.13, pp.2, 2015, https://doi.org/10.3892/mmr.2015.4692
  8. Association of miR-1266 with Recurrence/Metastasis Potential in Estrogen Receptor Positive Breast Cancer Patients vol.16, pp.1, 2015, https://doi.org/10.7314/APJCP.2015.16.1.291
  9. 低氧诱导因子与乳腺癌转移 vol.16, pp.1, 2015, https://doi.org/10.1631/jzus.B1400221
  10. and VEGF Effect on Cell Biological Behaviour vol.2015, pp.1875-8630, 2015, https://doi.org/10.1155/2015/325176
  11. MicroRNA-20b (miR-20b) Promotes the Proliferation, Migration, Invasion, and Tumorigenicity in Esophageal Cancer Cells via the Regulation of Phosphatase and Tensin Homologue Expression vol.11, pp.10, 2016, https://doi.org/10.1371/journal.pone.0164105
  12. RETRACTED ARTICLE: Upregulation of miR-20a and miR-10a expression levels act as potential biomarkers of aggressive progression and poor prognosis in cervical cancer vol.37, pp.12, 2016, https://doi.org/10.1007/s13277-015-4064-0
  13. CCmiR: a computational approach for competitive and cooperative microRNA binding prediction vol.34, pp.2, 2017, https://doi.org/10.1093/bioinformatics/btx606
  14. MiR-20a, a novel promising biomarker to predict prognosis in human cancer: a meta-analysis vol.18, pp.1, 2018, https://doi.org/10.1186/s12885-018-4907-3
  15. Reciprocal regulations between miRNAs and HIF-1α in human cancers pp.1420-9071, 2019, https://doi.org/10.1007/s00018-018-2941-6